Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder
Frank Christoph(Charité - Universitätsmedizin Berlin), Mark Schrader(Arbeitsgemeinschaft Urologische Onkologie), Martin Schostak(Aturo), Kurt Miller(Charité - Universitätsmedizin Berlin), Markus Müller(Charité - Universitätsmedizin Berlin), Karim Tabiti(Roche Pharma AG (Germany)), Steffen Weikert(German Institute of Human Nutrition), Ingmar Wolff(Universitätsmedizin Greifswald)
Cited by 26
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
|The Lancet Oncology|2015|1.4k
The Effect of Exercise Training Programs on Bone Mass: A Meta-analysis of Published Controlled Trials in Pre- and Postmenopausal Women
|Osteoporosis International|1999|594